Skip to main content
Disease Markers logoLink to Disease Markers
. 2026 Mar 2;2026:9804137. doi: 10.1155/dim/9804137

Correction to “KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells”

PMCID: PMC12955853  PMID: 41783332

T. Shen, L. Yang, Z. Zhang, J. Yu, L. Dai, M.Gao, Z. Shang, and Y. Niu. “KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells," Disease Markers, no. 2019 (2019), https://doi.org/10.1155/2019/4863182.

In the article titled “KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells,” there was an error in Table 1 related to the incorrect presentation of patients with “low” tumor grading. The error was introduced by the authors during the preparation of the manuscript and should be corrected as follows:

Table 1.

Relationships of KIF20A and the clinicopathological characteristics of 108 patients with bladder cancer.

Variables All n = 108 KIF20A p value#
Low High
n = 35 n = 73
Age
 <65 56 17 39 0.64
 ≥65 52 18 34 —
Sex
 Male 65 20 45 0.65
 Female 43 15 28 —
Tumor stage
 T2 54 23 31 0.02 ∗
 T3/T4 54 12 42 —
Tumor grade
 Low 54 24 30 0.01 ∗
 High 54 11 43 —
Lymph node metastasis
 No 45 20 25 0.02 ∗
 Yes 63 15 48 —
Distant metastasis
 No 60 20 40 0.82
 Yes 48 15 33 —
Vascular invasion
 No 54 23 31 0.02 ∗
 Yes 54 12 42 —

# p value was analyzed by chi‐square test;  ∗ indicates p < 0.05 with statistical significance.

We apologize for this error.


Articles from Disease Markers are provided here courtesy of Wiley

RESOURCES